Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary Assertio Therapeutics Announces First-Quarter 2019 Financial Results
-- Reports Neurology Franchise Net Sales of $26.3 million -- -- Commercialization Agreement Revenues of $30.9 million -- -- Raises 2019 Earnings Guidance Range and Confirms Neurology Franchise Net Sales Guidance -- -- Significant Debt Reduction -- LAKE FOREST, Ill.
Toggle Summary Assertio Therapeutics to Report First Quarter 2019 Financial Results After The Close of Markets on Wednesday, May 8, 2019
LAKE FOREST, Ill. , April 24, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release first quarter 2019 financial results on Wednesday, May 8, 2019 , after the close of markets. Following the announcement, the Company will host a conference call
Toggle Summary Assertio Therapeutics Announces Appointment of Jay Galeota to Board of Directors
LAKE FOREST, Ill. , April 01, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that James (Jay) J. Galeota, Jr. has been appointed to the Company’s Board of Directors. Mr. Galeota most recently served as the President and Chief Operating Officer of G&W

Upcoming Events

There are currently no events to display.
Presentations

Recent SEC Filings

Filing date Description Form Filing Group View

Optional form for the registration of securities to be sold to the public by small business issuers

SB-2
Registration Statements
View HTML

Pre-effective amendment to an SB-2 filing

SB-2/A
Registration Statements
View HTML

Registration of certain classes of securities 12(b) of the Securities Exchange Act

8-A12B
Registration Statements
View HTML

Substantive changes from or additions to a prospectus previously filed

424A
Registration Statements
View HTML

Pre-effective amendment to an SB-2 filing

SB-2/A
Registration Statements
View HTML

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA
 

Investor Relations Contact

John B. Thomas
SVP, Investor Relations & Corporate Communications
jthomas@assertiotx.com